Selected article for: "low lymphocyte proportion and lymphocyte proportion"

Author: Yang, Penghui; Ding, Yibo; Xu, Zhe; Pu, Rui; Li, Ping; Yan, Jin; Liu, Jiluo; Meng, Fanping; Huang, Lei; Shi, Lei; Jiang, Tianjun; Qin, Enqiang; Zhao, Min; Zhang, Dawei; Zhao, Peng; Yu, Lingxiang; Wang, Zhaohai; Hong, Zhixian; Xiao, Zhaohui; Xi, Qing; Zhao, Dexi; Yu, Peng; Zhu, Caizhong; Chen, Zhu; Zhang, Shaogeng; Ji, Junsheng; Cao, Guangwen; Wang, Fusheng
Title: Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China
  • Cord-id: 2vdvswda
  • Document date: 2020_3_3
  • ID: 2vdvswda
    Snippet: Background:SARS-CoV-2-caused coronavirus disease (COVID-19) is posinga large casualty. The features of COVID-19patients withand without pneumonia,SARS-CoV-2 transmissibility in asymptomatic carriers, and factors predicting disease progression remain unknown. Methods: We collected information on clinical characteristics, exposure history, andlaboratory examinations of all laboratory-confirmed COVID-19 patients admitted to PLA General Hospital. Cox regression analysis was applied to identify progn
    Document: Background:SARS-CoV-2-caused coronavirus disease (COVID-19) is posinga large casualty. The features of COVID-19patients withand without pneumonia,SARS-CoV-2 transmissibility in asymptomatic carriers, and factors predicting disease progression remain unknown. Methods: We collected information on clinical characteristics, exposure history, andlaboratory examinations of all laboratory-confirmed COVID-19 patients admitted to PLA General Hospital. Cox regression analysis was applied to identify prognostic factors. The last follow-up was February 18, 2020. Results:We characterized 55 consecutive COVID-19 patients. The mean incubation was 8.42(95% confidence interval [CI], 6.55-10.29) days. The mean SARS-CoV-2-positive duration from first positive test to clearance was 9.71(95%CI, 8.21-11.22) days. COVID-19 course was approximately 2 weeks. Asymptomatic carriers might transmit SARS-CoV-2. Compared with patients without pneumonia, those with pneumonia were 15 years older and had a higher rate of hypertension, higher frequencies of having a fever and cough, and higher levels of interleukin-6 (14.61 vs. 8.06pg/mL, P=0.040), B lymphocyte proportion (13.0% vs.10.0%, P=0.024), low account (<190/μL) of CD8+ T cells (33.3% vs. 0, P=0.019). Multivariate Cox regression analysis indicated that circulating interleukin-6 andlactate independently predicted COVID-19 progression, with a hazard ratio (95%CI) of 1.052 (1.000-1.107) and 1.082 (1.013-1.155), respectively. During disease course,T lymphocytes were generally lower,neutrophils higher, in pneumonia patients than in pneumonia-free patients. CD8+ lymphocytes did not increase at the 20th days after illness onset. Conclusion: The epidemiological features areimportant for COVID-19 prophylaxis. Circulating interleukin-6 and lactateare independent prognostic factors. CD8+ T cell exhaustion might be critical in the development of COVID-19.

    Search related documents:
    Co phrase search for related documents
    • acute stage and admission lactate serum: 1
    • acute stage and admission pneumonia: 1
    • acute stage and lopinavir ritonavir: 1
    • acute stage and lung inflammation: 1, 2
    • acute stage and lymphocyte count: 1, 2
    • acute stage high level and admission lactate: 1
    • acute stage high level and admission lactate serum: 1
    • admission identify and lopinavir ritonavir: 1
    • admission identify and lung inflammation: 1
    • admission identify and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • admission lactate and lopinavir ritonavir: 1, 2, 3
    • admission lactate and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • admission lactate and lymphocyte proportion: 1
    • admission lactate serum and lymphocyte count: 1, 2, 3, 4
    • admission onset mean duration and lopinavir ritonavir: 1
    • admission pneumonia and lopinavir ritonavir: 1, 2, 3, 4, 5, 6
    • admission pneumonia and lung lesion: 1
    • admission pneumonia and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • local polynomial regression and loess local polynomial regression: 1, 2